Cerity Partners LLC cut its holdings in shares of Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 6.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 76,884 shares of the specialty chemicals company's stock after selling 5,692 shares during the period. Cerity Partners LLC owned about 0.37% of Hawkins worth $8,144,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bridges Investment Management Inc. increased its holdings in shares of Hawkins by 111.1% during the first quarter. Bridges Investment Management Inc. now owns 9,289 shares of the specialty chemicals company's stock worth $984,000 after buying an additional 4,888 shares in the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of Hawkins by 26.4% during the first quarter. Nisa Investment Advisors LLC now owns 981 shares of the specialty chemicals company's stock worth $104,000 after buying an additional 205 shares in the last quarter. Linden Thomas Advisory Services LLC increased its holdings in shares of Hawkins by 9.8% during the first quarter. Linden Thomas Advisory Services LLC now owns 13,977 shares of the specialty chemicals company's stock worth $1,480,000 after buying an additional 1,248 shares in the last quarter. DekaBank Deutsche Girozentrale increased its holdings in shares of Hawkins by 355.8% during the first quarter. DekaBank Deutsche Girozentrale now owns 11,934 shares of the specialty chemicals company's stock worth $1,257,000 after buying an additional 9,316 shares in the last quarter. Finally, TD Private Client Wealth LLC increased its holdings in shares of Hawkins by 40.0% during the first quarter. TD Private Client Wealth LLC now owns 661 shares of the specialty chemicals company's stock worth $70,000 after buying an additional 189 shares in the last quarter. 69.71% of the stock is currently owned by institutional investors.
Hawkins Trading Down 1.4%
NASDAQ HWKN traded down $2.21 on Friday, reaching $161.38. The company had a trading volume of 141,706 shares, compared to its average volume of 133,856. The firm has a market cap of $3.37 billion, a price-to-earnings ratio of 39.95, a P/E/G ratio of 2.73 and a beta of 0.85. Hawkins, Inc. has a fifty-two week low of $98.30 and a fifty-two week high of $166.28. The business has a 50 day moving average of $138.94 and a two-hundred day moving average of $121.63. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.15 and a quick ratio of 1.37.
Hawkins (NASDAQ:HWKN - Get Free Report) last issued its quarterly earnings results on Wednesday, May 14th. The specialty chemicals company reported $0.78 earnings per share for the quarter, topping analysts' consensus estimates of $0.74 by $0.04. Hawkins had a return on equity of 18.93% and a net margin of 8.66%. The firm had revenue of $245.32 million during the quarter, compared to the consensus estimate of $230.69 million. Analysts forecast that Hawkins, Inc. will post 4 EPS for the current year.
Hawkins Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 30th were issued a dividend of $0.18 per share. The ex-dividend date was Friday, May 30th. This represents a $0.72 dividend on an annualized basis and a yield of 0.45%. Hawkins's payout ratio is currently 17.82%.
Analyst Upgrades and Downgrades
HWKN has been the subject of several research analyst reports. CJS Securities initiated coverage on shares of Hawkins in a report on Tuesday, April 1st. They set a "market outperform" rating and a $125.00 price target for the company. BWS Financial reiterated a "buy" rating and set a $160.00 price target on shares of Hawkins in a report on Thursday, May 15th. Finally, Wall Street Zen downgraded shares of Hawkins from a "buy" rating to a "hold" rating in a report on Saturday, July 5th.
Read Our Latest Report on Hawkins
About Hawkins
(
Free Report)
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
See Also

Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.